1098 related articles for article (PubMed ID: 20542460)
1. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.
Melzer M; Gupta N; Petersen I; Cook S; Hall B
Int J Infect Dis; 2010 Aug; 14(8):e717-22. PubMed ID: 20542460
[TBL] [Abstract][Full Text] [Related]
2. Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm.
Simons SO; van der Laan T; Mulder A; van Ingen J; Rigouts L; Dekhuijzen PN; Boeree MJ; van Soolingen D
Clin Microbiol Infect; 2014 Oct; 20(10):1015-20. PubMed ID: 24890253
[TBL] [Abstract][Full Text] [Related]
3. Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains.
Al-Mutairi NM; Ahmad S; Mokaddas E
Int J Tuberc Lung Dis; 2011 Jan; 15(1):110-5. PubMed ID: 21276306
[TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007.
Bang D; Lillebaek T; Thomsen VØ; Andersen AB
Scand J Infect Dis; 2010 Apr; 42(4):288-93. PubMed ID: 20082573
[TBL] [Abstract][Full Text] [Related]
5. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
[TBL] [Abstract][Full Text] [Related]
6. Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil.
Esteves LS; Dalla Costa ER; Vasconcellos SEG; Vargas A; Ferreira Junior SLM; Halon ML; Ribeiro MO; Rodenbusch R; Gomes HM; Suffys PN; Rossetti MLR
Tuberculosis (Edinb); 2018 May; 110():36-43. PubMed ID: 29779771
[TBL] [Abstract][Full Text] [Related]
7. Mutations of
Tavanaee Sani A; Ashna H; Kaffash A; Khaledi A; Ghazvini K
Ethiop J Health Sci; 2018 May; 28(3):299-304. PubMed ID: 29983529
[TBL] [Abstract][Full Text] [Related]
8. Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment.
Ho J; Jelfs P; Sintchencko V
J Antimicrob Chemother; 2013 Dec; 68(12):2915-20. PubMed ID: 23838950
[TBL] [Abstract][Full Text] [Related]
9. Genotype MTBDR plus assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
Sharma S; Madan M; Agrawal C; Asthana AK
Indian J Pathol Microbiol; 2014; 57(3):423-6. PubMed ID: 25118735
[TBL] [Abstract][Full Text] [Related]
10. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
Valvatne H; Syre H; Kross M; Stavrum R; Ti T; Phyu S; Grewal HM
J Antimicrob Chemother; 2009 Oct; 64(4):694-701. PubMed ID: 19710078
[TBL] [Abstract][Full Text] [Related]
11. Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan.
Munir S; Mahmood N; Shahid S; Khan MI
Microb Pathog; 2017 Sep; 110():262-274. PubMed ID: 28688981
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates by multiple allele specific polymerase chain reaction in Puducherry, South India.
Thirumurugan R; Kathirvel M; Vallayyachari K; Surendar K; Samrot AV; Muthaiah M
J Infect Public Health; 2015; 8(6):619-25. PubMed ID: 26117709
[TBL] [Abstract][Full Text] [Related]
13. Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.
Metcalfe JZ; Makumbirofa S; Makamure B; Sandy C; Bara W; Mason P; Hopewell PC
Int J Tuberc Lung Dis; 2016 Jul; 20(7):882-9. PubMed ID: 27287639
[TBL] [Abstract][Full Text] [Related]
14. Real-time PCR followed by high-resolution melting curve analysis: A rapid and pragmatic approach for screening of multidrug-resistant extrapulmonary tuberculosis.
Sharma K; Sharma M; Singh S; Modi M; Sharma A; Ray P; Varma S
Tuberculosis (Edinb); 2017 Sep; 106():56-61. PubMed ID: 28802406
[TBL] [Abstract][Full Text] [Related]
15. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
Imperiale BR; Zumárraga MJ; Di Giulio AB; Cataldi AA; Morcillo NS
Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034
[TBL] [Abstract][Full Text] [Related]
16. [Population-based molecular epidemiologic study of rifampicin-resistant tuberculosis in rural area of eastern China].
Wang JJ; Hu Y; Jiang WL; Wang WB; Xu B
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1189-93. PubMed ID: 20193593
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from Ethiopia.
Biadglegne F; Mulu A; Rodloff AC; Sack U
Tuberculosis (Edinb); 2014 Sep; 94(5):502-5. PubMed ID: 24931451
[TBL] [Abstract][Full Text] [Related]
19. Microscopic observation drug susceptibility assay in the diagnosis of multidrug-resistant tuberculosis.
Rasslan O; Hafez SF; Hashem M; Ahmed OI; Faramawy MA; Khater WS; Saleh DA; Mohamed MI; Khalifa MA; Shoukry FA; El-Moghazy EH
Int J Tuberc Lung Dis; 2012 Jul; 16(7):941-6. PubMed ID: 22584201
[TBL] [Abstract][Full Text] [Related]
20. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
